ADAMAS PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT June 30, 2011Investors’ Rights Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 5th, 2014 Company Industry JurisdictionThis Fourth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of June 30, 2011, by and among Adamas Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the persons and entities listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors” or “Preferred Holders”) and the persons and entities listed on Exhibit B hereto (each, a “Common Holder” and collectively, the “Common Holders”). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
ADAMAS PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT June 30, 2011Investors’ Rights Agreement • January 31st, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 31st, 2014 Company Industry JurisdictionThis Fourth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of June 30, 2011, by and among Adamas Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the persons and entities listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors” or “Preferred Holders”) and the persons and entities listed on Exhibit B hereto (each, a “Common Holder” and collectively, the “Common Holders”). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.